This review suggests that the field of nuclear cardiology is alive, well, a
nd thriving, providing relevant information that aids in everyday clinical
decision making for nuclear medicine and referring physicians alike. Despit
e the competition from other modalities, the clinically appropriate applica
tions of nuclear cardiology techniques are likely to increase. The foundati
on of this optimism is based on the vast amount of data documenting cost-ef
fective clinical applications for diagnosis, risk stratification, and asses
sing therapy in both chronic and acute coronary artery disease (CAD), the p
owerful objective quantitative analysis of perfusion and function provided
by the technique, and the increasing general availability of the approach.
Copyright (C) 1999 by W.B. Saunders Company.